Exploiting a research underclass in phase 1 clinical trials

Carl Elliott; Roberto Abadie

doi:10.1056/NEJMp0801872

Exploiting a research underclass in phase 1 clinical trials

Carl Elliott
, Roberto Abadie

Philosophy (Twin Cities)

Research output: Contribution to journal › Article › peer-review

91 Scopus citations

Original language	English (US)
Pages (from-to)	2316-2317
Number of pages	2
Journal	New England Journal of Medicine
Volume	358
Issue number	22
DOIs	https://doi.org/10.1056/NEJMp0801872
State	Published - May 29 2008

Publisher link

10.1056/NEJMp0801872

Find It

Find It at U of M Libraries

Cite this

@article{6045c34ad0404f5980fef217df1caa39,

title = "Exploiting a research underclass in phase 1 clinical trials",

author = "Carl Elliott and Roberto Abadie",

year = "2008",

month = may,

day = "29",

doi = "10.1056/NEJMp0801872",

language = "English (US)",

volume = "358",

pages = "2316--2317",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Exploiting a research underclass in phase 1 clinical trials

AU - Elliott, Carl

AU - Abadie, Roberto

PY - 2008/5/29

Y1 - 2008/5/29

UR - https://www.scopus.com/pages/publications/44349179842

UR - https://www.scopus.com/pages/publications/44349179842#tab=citedBy

U2 - 10.1056/NEJMp0801872

DO - 10.1056/NEJMp0801872

M3 - Article

C2 - 18509119

AN - SCOPUS:44349179842

SN - 0028-4793

VL - 358

SP - 2316

EP - 2317

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 22

ER -

Exploiting a research underclass in phase 1 clinical trials

Publisher link

Find It

Other files and links

Cite this